Sie sind auf Seite 1von 2

DRUG STUDY

GENERIC BRAND DRUG DOSAGE & HOW MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS RESPONSIBILITY
NAME NAME CLASSIFICATION FREQUENCY SUPPLIED & ACTION (Before, During,
ROUTE After
Administration)
Tranexami Hemostan Antifibronlytic 500mg IVTT Inhibits activation Treatment of Hypersensitive to drug CNS: confusion, Before:
c acid Q 8h of plasminogen excessive Active intravascular restlessness, Observe 7 rights
thereby reducing bleeding clotting weakness of drug
conversion of Subarachnoid administration
plasminogen to hemorrhage GI: nausea, Assess history of
plasmin. An vomiting, hypotension
enzyme that anorexia, During:
degrades fibrin flatulence Administer drug
clots and other at right route and
plasma proteins. CV: dosage in the right
hypotension, time
thromboembol After:
ism Unusual change
in bleeding
pattern should be
reported to
physician.
Store medication
in room temp.
Report severe
allergic reaction
like swelling of
tongue, mouth,
face